Debra L Laskin Selected Research

Proliferating Cell Nuclear Antigen (PCNA)

10/2021	Pulmonary injury and oxidative stress in rats induced by inhaled sulfur mustard is ameliorated by anti-tumor necrosis factor-α antibody.
1/2016	Mitigation of nitrogen mustard mediated skin injury by a novel indomethacin bifunctional prodrug.
10/2011	Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Debra L Laskin Research Topics

Disease

53	Inflammation (Inflammations) 05/2024 - 04/2002
41	Lung Injury 05/2024 - 04/2002
16	Fibrosis (Cirrhosis) 05/2023 - 12/2012
13	Edema (Dropsy) 10/2021 - 12/2010
12	Acute Lung Injury 05/2024 - 08/2014
11	Necrosis 07/2012 - 04/2002
10	Endotoxemia 05/2024 - 01/2002
9	Pneumonia (Pneumonitis) 05/2024 - 04/2002
7	Hyperplasia 05/2024 - 04/2002
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 03/2007
7	Wounds and Injuries (Trauma) 01/2019 - 07/2012
6	Poisoning 02/2020 - 02/2011
5	Neoplasms (Cancer) 01/2021 - 03/2008
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2024 - 02/2011
4	Chronic Disease (Chronic Diseases) 04/2024 - 01/2019
4	Lung Diseases (Lung Disease) 12/2017 - 05/2002
3	Asthma (Bronchial Asthma) 01/2019 - 08/2010
3	Infections 01/2018 - 01/2004
2	Dyslipidemias (Dyslipidemia) 01/2023 - 10/2020
2	Ataxia Telangiectasia (Louis Bar Syndrome) 06/2020 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 12/2017
2	Bronchiolitis 06/2013 - 01/2011
1	Sepsis (Septicemia) 05/2024
1	Hemorrhage 03/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Surfactant Dysfunction 01/2023
1	Corneal Injuries 10/2022

Drug/Important Bio-Agent (IBA)

26	Irritants (Vesicants)IBA 04/2024 - 06/2010
20	OzoneIBA 05/2024 - 04/2002
20	Mechlorethamine (Nitrogen Mustard)FDA Link 04/2024 - 01/2011
15	Mustard Gas (Sulfur Mustard)IBA 10/2022 - 06/2010
11	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2002
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 10/2002
11	Acetaminophen (Paracetamol)FDA LinkGeneric 07/2012 - 05/2002
9	Alkylating AgentsIBA 01/2021 - 10/2011
6	Transaminases (Aminotransferases)IBA 07/2012 - 11/2003
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2015 - 04/2002
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2012 - 04/2002
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2011 - 04/2002
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 05/2024 - 10/2013
4	LipopolysaccharidesIBA 02/2023 - 01/2002
4	Surface-Active Agents (Surfactants)IBA 01/2023 - 09/2012
4	CytokinesIBA 01/2023 - 01/2016
4	Reactive Nitrogen SpeciesIBA 01/2019 - 08/2010
4	NitrogenIBA 01/2016 - 05/2002
3	FibrinIBA 03/2024 - 12/2012
3	LipidsIBA 05/2023 - 12/2019
3	ChlorineIBA 01/2023 - 07/2014
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2021 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 10/2007
3	Connective Tissue Growth FactorIBA 01/2019 - 01/2011
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 03/2004
3	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 05/2002
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2016 - 10/2010
3	Oxygen (Dioxygen)IBA 01/2016 - 05/2002
3	Galectin 3 (LGALS3)IBA 04/2015 - 09/2012
3	2-chloroethyl ethyl sulfideIBA 05/2012 - 12/2010
3	EicosanoidsIBA 06/2010 - 04/2002
3	NF-kappa B (NF-kB)IBA 10/2007 - 03/2002
2	Phospholipids (Phosphatides)FDA LinkGeneric 05/2024 - 11/2018
2	Immunoglobulin M (IgM)IBA 05/2024 - 01/2023
2	EndotoxinsIBA 05/2024 - 01/2020
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 03/2024 - 08/2014
2	AerosolsIBA 01/2023 - 01/2023
2	Fibrinogen (Factor I)FDA Link 01/2023 - 10/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 08/2010
2	CollagenIBA 12/2020 - 02/2005
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2020 - 05/2002
2	ChemokinesIBA 11/2020 - 03/2016
2	LigandsIBA 10/2020 - 10/2002
2	DNA-Activated Protein KinaseIBA 06/2020 - 01/2019
2	AcidsIBA 01/2020 - 01/2018
2	Parathion (Ethyl Parathion)IBA 01/2016 - 10/2015
2	Protein CIBA 08/2014 - 09/2012
2	LipocalinsIBA 08/2014 - 10/2007
2	Toll-Like Receptor 4IBA 02/2013 - 12/2007
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 11/2009
2	Peroxynitrous Acid (Peroxynitrite)IBA 03/2008 - 08/2004
1	Receptor for Advanced Glycation End ProductsIBA 05/2024
1	AlbuminsIBA 05/2024
1	N-(3-pyridylmethyl)adriamycin (YM 1)IBA 03/2024
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2024
1	C.I. direct red 80IBA 05/2023
1	Hydroxyproline (4 Hydroxyproline)IBA 05/2023
1	Phosphates (Orthophosphate)IBA 05/2023
1	obeticholic acidIBA 05/2023
1	XenobioticsIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Nylons (Nylon)IBA 01/2023
1	IgA receptor (protein B)IBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	S-NitrosothiolsIBA 12/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2022
1	Blood Proteins (Serum Proteins)IBA 10/2021
1	indium-bleomycinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	Histones (Histone)IBA 01/2021
1	Chemical Warfare AgentsIBA 11/2020

Therapy/Procedure

10	Therapeutics 05/2023 - 11/2009